DGAP-News

Rentschler Biopharma donates 50,000 Euros to support construction of the Albert Einstein Discovery Center in Ulm - Seite 2

Dr. Nancy Hecker-Denschlag, Chairwoman of the Albert Einstein Discovery Center Ulm e.V., is pleased that Rentschler Biopharma, a leading biopharmaceutical company from the region, has joined the group of lead sponsors, called 'The First 11'. "Rentschler Biopharma is a perfect fit with the future Albert Einstein Discovery Center Ulm because its focus is not only on providing scientific knowledge, but also on offering activities in the 'hands-on science center' we are planning. This is intended to create enthusiasm, especially among young people, for learning about math and science."

To implement the project, the 'First 11' campaign aims to motivate more companies to become sponsors. The company names and logos of the 11 lead sponsors will be hung in the foyer of the Albert Einstein Discovery Center. They also will receive a total of 100 plaques with a stone from Albert Einstein's birthplace. "We are delighted to see that more and more companies are becoming interested in our idea. Not only is membership in our association increasing, but a number of companies are approaching us to offer support. That is why I am optimistic that we soon will be able to announce the next sponsors in 'The First 11'," said Dr. Hecker-Denschlag.

About Rentschler Biopharma SE

Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals as well as related consulting activities, including project management and regulatory support. Rentschler Biopharma's high quality is proven by its long-standing experience and excellence as a solution partner for its clients. A high-level quality management system, a well-established operational excellence philosophy and advanced technologies ensure product quality and productivity at each development and manufacturing step. In order to offer best-in-class formulation development along the biopharmaceutical value chain, the company has entered into a strategic alliance with Leukocare AG. Rentschler Biopharma is a family-owned company with about 1,100 employees, headquartered in Laupheim, Germany, with a second site in Milford, MA, USA. In Stevenage, UK, Rentschler Biopharma has launched a company dedicated to cell and gene therapies, Rentschler ATMP Ltd.